These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8943774)

  • 1. Effects of somatostatin-28 on circulating concentrations of insulin and gut hormones in sheep.
    Martin PA; Faulkner A
    J Endocrinol; 1996 Oct; 151(1):107-12. PubMed ID: 8943774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin secretion and intestinal peptides during lactation in sheep.
    Faulkner A; Martin PA
    J Dairy Res; 1999 Feb; 66(1):45-52. PubMed ID: 10191472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas.
    Fehmann HC; Göke R; Göke B; Bächle R; Wagner B; Arnold R
    Biochim Biophys Acta; 1991 Feb; 1091(3):356-63. PubMed ID: 1705823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide.
    Kolligs F; Fehmann HC; Göke R; Göke B
    Diabetes; 1995 Jan; 44(1):16-9. PubMed ID: 7813808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    Digestion; 1992; 52(3-4):214-21. PubMed ID: 1459356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of somatostatin-28 on plasma glucose-dependent insulinotropic polypeptide and serum insulin concentrations.
    Faulkner A; Martin PA
    Biochem Soc Trans; 1995 Nov; 23(4):544S. PubMed ID: 8654729
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.
    Sandhu H; Wiesenthal SR; MacDonald PE; McCall RH; Tchipashvili V; Rashid S; Satkunarajah M; Irwin DM; Shi ZQ; Brubaker PL; Wheeler MB; Vranic M; Efendic S; Giacca A
    Diabetes; 1999 May; 48(5):1045-53. PubMed ID: 10331409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
    Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
    J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
    Meier JJ; Kemmeries G; Holst JJ; Nauck MA
    Diabetes; 2005 Jul; 54(7):2212-8. PubMed ID: 15983224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones.
    Toft-Nielson M; Madsbad S; Holst JJ
    Diabetes; 1996 May; 45(5):552-6. PubMed ID: 8621002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
    Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 does not not acutely affect insulin sensitivity in healthy man.
    Orskov L; Holst JJ; Møller J; Orskov C; Møller N; Alberti KG; Schmitz O
    Diabetologia; 1996 Oct; 39(10):1227-32. PubMed ID: 8897012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of truncated glucagon-like peptide-1 on the responses of starved sheep to glucose.
    Faulkner A; Pollock HT
    J Endocrinol; 1991 Apr; 129(1):55-8. PubMed ID: 2030330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects.
    Meier JJ; Nauck MA; Kranz D; Holst JJ; Deacon CF; Gaeckler D; Schmidt WE; Gallwitz B
    Diabetes; 2004 Mar; 53(3):654-62. PubMed ID: 14988249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue.
    Oben J; Morgan L; Fletcher J; Marks V
    J Endocrinol; 1991 Aug; 130(2):267-72. PubMed ID: 1919397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
    Gutniak MK; Juntti-Berggren L; Hellström PM; Guenifi A; Holst JJ; Efendic S
    Diabetes Care; 1996 Aug; 19(8):857-63. PubMed ID: 8842604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
    Nauck MA; Niedereichholz U; Ettler R; Holst JJ; Orskov C; Ritzel R; Schmiegel WH
    Am J Physiol; 1997 Nov; 273(5):E981-8. PubMed ID: 9374685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.